// App-Quantinova.ai

101 : CHRONIC KIDNEY DISEASE AUGMENTS CARDIOVASCULAR RISK: MODULATION OF MYOCARDIAL BLOOD FLOW REGULATION AND CYP450 ARACHIDONIC ACID METABOLITES

Researchers

Presenter

  • D. Simard

Principal Investigators

  • D. Patoine

  • S. Pilote

  • B. Drolet

  • J.R. Rouleau

  • C. Simard

Medical Centers

  • Laval University, Faculty of Pharmacy, Quebec, Quebec, Canada

  • CRIUSMQ, Quebec, Quebec, Canada

  • Laval University, Dept. Medicine, Quebec, Quebec, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic kidney disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Creatinine

  • Translocator protein

Drug/Treatment

  • Dobutamine

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved